Research Paper Volume 12, Issue 22 pp 22776—22793

Immune-related biomarker risk score predicts prognosis in prostate cancer

class="figure-viewer-img"

Figure 8. Differences in immune characteristics between the high and low risk score groups. (A) Expression of 75 immunomodulators in the high and low risk groups. “*” indicates a difference in expression between the high and low risk groups. (B) Immune-related GSEA enrichment analysis.